Cancer screenings in US continued to lag during year 2 of pandemic

Rates of past-year screening for breast, cervical and prostate cancer in 2021 remained below prepandemic levels as millions of eligible Americans continued to forgo testing, according to a study published in Journal of Clinical Oncology.However, rates of colorectal cancer screening did not change between 2019 and the second year of the COVID-19 pandemic, as a rise in past-year stool testing offset a decrease in colonoscopy screening, researchers wrote.Previous studies showed declines in cancer screening rates during the first peak of the COVID-19 pandemic and afterward. However, because theseRead More